Page 138 - CW E-Magazine (23-4-2024)

Pharmaceuticals Hydrocarbons

POOLING RESOURCES IMPORT & STORAGE FACILITY
Serum Institute of India and Belgium’s Univercells Petregaz India commissions LPG terminal

announce personalised cancer treatment collaboration at Krishnapatnam

Serum Institute of India (SII), the medicines compared to traditional Petregaz India, a subsidiary of large and small and supporting India’s
Pune based vaccine major, has joined approaches.” Singapore-based LPG shipping and energy transition away from heavier,
forces with Univercells, a Belgian bio- trading company, Petredec Group, has higher polluting hydrocarbons to cleaner
tech innovator, targeting a dramatic Critically, Univercells’ technology inaugurated its new LPG import and burning, affordable and accessible
increase in accessibility to personalised also supports very-small scale, local storage terminal at Krishnapatnam, LPG,” he added.
cancer care. This partnership aims to production. This allows countries, and Andhra Pradesh.
bring cutting edge treatment options even hospitals, to provide personalised Petredec is an integrated LPG com-
within reach of millions globally. therapies produced locally. “With SII’s The newly commissioned facility, pany that trades, transports and distri-
global reach, these therapies can reach with an investment of Rs. 600-crore, butes LPG around the world. Petredec
At present, personalised care be a boon for cancer treatment across patients in Europe, India and the African enables Petregaz to deliver “cost- owns and operates a large and modern
options such as novel cancer vaccines the world, especially in the LMICs continent,” the companies said. effective and dependable solutions” to land, optimising logistics and strength- fl eet of 35 LPG carriers, mainly
and specialised immunotherapies are (low-and middle-income countries),” LPG marketers as well as residential, ening India’s LPG landscape. This VLGCs. Petredec has a growing pre-
accessible to a few patients only. These said Dr. Umesh Shaligram, Executive Longer term, Univercells and SII commercial, industrial and automotive new facility will also benefi t private sence in the LPG downstream sector
new therapies are developed using Director, R&D, SII. “Relapse rates for believe that they may be able to drama- customers. The terminal is located marketers and bottlers by improving with three LPG import terminals in the
genetic material extracted from the many cancers are very high, especially tically accelerate the progress of new within Adani’s Krishnapatnam port, access to LPG in an area of the country Indian Ocean.
patient’s tumours, a process which is for patients who are diagnosed at a later medicines. At present, the average 25-kms from Nellore. The terminal historically underdeveloped in terms of
both time-consuming, and expensive. stage. To address this, we are develop- time for a cancer therapy to go from includes two refrigerated storage tanks – LPG infrastructure,” Mr. Susheel Raina, Petregaz is the Petredec Group’s
Besides, due to strict regulatory limi- ing unique point-of-care cancer treat- patenting to use by patients is close to one each for propane and butane, each CEO, of Petregaz India, said in a downstream subsidiary, specialising in
tations on the sequence, transfer, and ment using mRNA in combination with 15 years in the UK. with 30,410-cbm capacity. release. LPG import, storage and large-scale
manufacturing of genetic material, our Recombinant BCG (VPM1002),” distribution of LPG. In India, Petregaz
these treatments are only available in a he added “Our target is to reduce that delay to “Government-run oil companies “With the launch of the new termi- Krishnapatnam Pvt. Ltd. is located on the
handful of countries. This collaboration just 3 years. We have many barriers to can utilise our terminal’s capacity to nal, we look forward to working with premises of the Adani Krishnapatnam
between SII and Univercells will help “Our technology can cut months off overcome, but because we can automate improve LPG supplies in the hinter- a host of new customers and partners, Port Pvt. Ltd.
in addressing these challenges, with the time to create a personalised thera- the system, we believe we can produce
a view to capture a proportion of the peutic without compromising quality.” personalised therapeutics which still OUTLOOK
global cancer care market. said Mr. José Castillo, Chief Techno- meet the highest standards of quality and
logy Offi cer & co-founder of Univer- are acceptable to the regulators. There ‘India accounts for 20% of upcoming regasifi cation
“We are excited about this collab- cells. “We’ve completely redesigned are breakthroughs all the time, but too
oration with Univercells with an aim the manufacturing process from fi rst many are coming too late for the patients capacity in Asia Pacifi c’
to strengthen the accessibility of can- principles and believe that we can save who need them. This partnership will
cer care therapies, which may prove to up to 90% of costs of producing these help us change that” said Mr. Castillo. India, the world’s fourth largest with a signifi cant 82 percent primarily
liquefi ed natural gas (LNG) importer, situated within the legacy JKT (Japan,
US FDA completes inspection of Lupin’s Dabhasa is expanding its natural gas infra- South Korea, Chinese Taipei) group,
structure by adding 24-mn tonnes per
constituting 64 percent and China with
facility annum (mtpa) of capacity accounting 18 percent. The rest, comprising South
for around 20 percent of the total
and Southeast Asia, contributed to the
Lupin has announced that the United “We are pleased to announce the regasifi cation capacity being added in remaining 18 percent. Among these,
States Food and Drug Administration successful completion of the US FDA Asia Pacifi c. Japan leads with 210-mtpa, followed
(U.S. FDA) has completed a GMP inspection of our Dabhasa facility. by South Korea (139-mtpa), China
inspection of its API manufacturing This accomplishment underscores our As per the latest annual report of (100-mtpa) and India (40-mtpa).
facility located at Dabhasa, Gujarat. unwavering dedication to maintaining the Gas Exporting Countries Forum
the highest standards of quality and (GECF), India will be the world’s larg- “In 2022, construction was under-
The inspection was conducted compliance in all aspects of our opera- est growth market for natural gas in the The GECF report pointed out that way for approximately 121-mtpa of
from April 8 to April 12, 2024 and tions,” said Mr. Nilesh Gupta, Manag- next decade with China claiming the Asia-Pacifi c boasted of around 566- regasifi cation capacity in Asia Pacifi c,
concluded with no observations. ing Director, Lupin. top spot till 2030. mtpa of regasifi cation capacity in 2022, with China (74-mtpa) and India (24-mtpa)

138 Chemical Weekly April 23, 2024 Chemical Weekly April 23, 2024 139

Contents Index to Advertisers Index to Products Advertised